Image 1
Balziva Kit
Product Images NDC 0555-9034
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Balziva (NDC 0555-9034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This text appears to be a table showing mortality rates (number of deaths per 100,000 women users) in relation to age and use of tobacco. The table is divided into categories of ever-users (smokers and nonsmokers) and controls (smokers and nonsmokers). The age categories are 15-24, 25-34, 35-44, and 45+. It is unclear what the source or context of this table is for.*
Image 3
This appears to be a combination of study names, dates, types of use (ever/current), and effect estimates (OR/RR), but without context, it is not immediately clear what the text represents or what the effect estimates are measuring.*
Image 4
Image 5
Image 6
This appears to be a description of a medication named Balzira, which is a combination birth control pill that contains norethindrone and ethinyl estradiol. The packaging contains 6 blister card dispensers, each with 28 tablets, and the NDC number is 0555903452. Additionally, the product may help prevent pregnancy and sexually transmitted diseases. The last line of the text contains some unclear characters, likely due to errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
